Carglumic acid

FDA Drug Profile — Carglumic acid

Carglumic acid is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Carglumic acid. Available dosage forms: powder, tablet, for suspension.

Drug details

Generic Name
Carglumic acid
Brand Names
Carglumic acid
Application Number
ANDA213395
Sponsor
Dipharma Francis S.R.L.
NDC Codes
4
Dosage Forms
POWDER, TABLET, FOR SUSPENSION
Routes
ORAL
Active Ingredients
CARGLUMIC ACID

Indications and Usage

1 INDICATIONS & USAGE Carglumic acid tablets for oral suspension is a carbamoyl phosphate synthetase 1 (CPS 1) activator indicated in pediatric and adult patients as: Adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. (1.1) Maintenance therapy for the treatment of chronic hyperammonemia due to NAGS deficiency. (1.1) 1.1 Acute and Chronic Hyperammonemia due to N-acetylglutamate Synthase (NAGS) Deficiency Carglumic acid tablets for oral suspension are indicated in adult and pediatric patients as: Adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to NAGS deficiency. Maintenance therapy for the treatment of chronic hyperammonemia due to NAGS deficiency.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.